Bluejay Diagnostics (BJDX) Current Taxes (2025 - 2026)
Bluejay Diagnostics recorded quarterly Current Taxes of $40000.0 in Q1 2026, down 70.62% quarter-over-quarter from $136149.0 in Q4 2025, and down 67.1% year-over-year from $121568.0 in Q1 2025.
Bluejay Diagnostics' Current Taxes history runs 2 years deep, the most recent figure standing at $40000.0 for Q1 2026.
- In Q1 2026, Current Taxes fell 67.1% year-over-year to $40000.0; the TTM figure through Mar 2026 stood at $40000.0 (down 67.1% YoY), while the FY2025 annual figure was $136149.0, changed N/A from the prior year.
- Current Taxes came in at $40000.0 for Q1 2026 at Bluejay Diagnostics, down from $136149.0 in the prior quarter.
- In the past five years, Current Taxes ranged from a high of $136149.0 in Q4 2025 to a low of $40000.0 in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 598.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 476.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 650.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 231.81 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 28.60 Mn |
| 10 | Bluejay Diagnostics | 572,394.44 | -3.11 Mn | - | 40,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40,000.00 |
| Dec 31, 2025 | 136,149.00 |
| Sep 30, 2025 | 68,074.00 |
| Jun 30, 2025 | 68,074.00 |
| Mar 31, 2025 | 121,568.00 |